Assemblin has been tasked with an upgrade of AstraZeneca's Gärtuna production plant in Södertälje, Sweden. The project entails multi-technical installations and general construction ...

AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...

In a shock move, AstraZeneca has ditched a plan to invest £450 million ($558 million) in a new vaccine manufacturing plant in the UK, after the government reduced the offer on the table to ...

AstraZeneca is backing up its considerable ... Chief executive Pascal Soriot said the plant will help AZ achieve its ambition to position ADCs as a replacement for traditional chemotherapies ...

Insurer EmblemHealth is leading a class-action lawsuit against a subsidiary of AstraZeneca, claiming that the company blocked competition for a pricey, rare blood disease medication and ...

GSK eventually pared back from the Chinese market, shuttering a research site and divesting a manufacturing plant. The circumstances are very different though, and AstraZeneca’s response compared to ...

Many drugs use active ingredients that are manufactured outside the U.S., among them the anticoagulant heparin, which 12 million patients use each year. Meanwhile, AstraZeneca's Chairman Michel Demaré ...

AstraZeneca saw its share price decline by 3.5% in the last quarter, a period marked by several key developments, including the European approval of DATROWAY for breast cancer treatment and ...